29London

Wednesday, 12 August 2020

Flipping a metabolic switch to slow tumor growth

The enzyme serine palmitoyl-transferase can be used as a metabolically responsive “switch” that decreases tumor growth, according to a new study by a team of San Diego scientists, who published their findings Aug. 12 in the journal Nature. By restricting the dietary amino acids serine and glycine, or pharmacologically targeting…

Nanotubes in the eye that help us see

A new mechanism of blood redistribution that is essential for the proper functioning of the adult retina has just been discovered in vivo by researchers at the University of Montreal Hospital Research Centre (CRCHUM). Their study was published today in Nature. “For the first time, we have identified a communication…

Corona-pandemic: WHO, reluctant at the Russian vaccine

The Corona-pandemic keeps the world in suspense: More than 20 million people have been infected so far worldwide, with the Coronavirus, 217.768 of them in Germany. The world health organization WHO has responded with restraint to the Russian President Vladimir Putin announced the approval of a Corona vaccine. The WHO…

Clinical trial focuses on reducing overactive immune response in COVID-19

Researchers at Washington University School of Medicine in St. Louis are investigating whether a drug approved by the Food and Drug Administration (FDA) to treat rare diseases of an overactive immune system could help critically ill patients hospitalized with COVID-19. The drug blocks a specific protein of the immune system…

Russia vaccine claim faces scepticism as nations renew virus battle

Russia claimed Tuesday it has developed the world’s first vaccine offering “sustainable immunity” against the coronavirus, despite mounting scepticism about its effectiveness as fears grow over a second wave of infections across the globe. President Vladimir Putin said the vaccine was safe and that one of his own daughters had…